Skip to main content
Top
Published in: Annals of Surgical Oncology 6/2016

01-06-2016 | Gastrointestinal Oncology

Effect of EGFR and p-AKT Overexpression on Chromosomal Instability in Gastric Cancer

Authors: Yuichi Hisamatsu, MD, PhD, Eiji Oki, MD, PhD, Hajime Otsu, MD, Koji Ando, MD, PhD, Hiroshi Saeki, MD, PhD, Eriko Tokunaga, MD, PhD, Shinichi Aishima, MD, PhD, Masaru Morita, MD, PhD, Yoshinao Oda, MD, PhD, Yoshihiko Maehara, MD, PhD

Published in: Annals of Surgical Oncology | Issue 6/2016

Login to get access

Abstract

Background

Molecular profiling in gastric cancer (GC) is important for diagnosis and treatment. In this study, we investigated signal transduction pathways that might induce chromosomal instability in GC.

Methods

Epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and p-AKT expression were analyzed using immunohistochemistry, and chromosomal instability was assessed by DNA aneuploidy using laser scanning cytometry, in a total of 202 GC cases.

Results

The rate of EGFR expression and p-AKT expression was 70.3 and 34.2 %, respectively, in GC patients. In total, 57.5 % of GC patients exhibited DNA aneuploidy, and p-AKT positively correlated with EGFR and HER2 (p = 0.0127 and p = 0.00031, respectively). Patients with EGFR overexpressing GC showed shorter disease-specific survival than the other cases (hazard ratio 2.00, 95 % confidence interval 1.19–3.53; p = 0.0104). Moreover, EGFR and p-AKT expression was significantly correlated with DNA aneuploidy (p = 0.0002 and p = 0.0302, respectively).

Conclusions

Our data showed that both EGFR and p-AKT overexpression were clearly associated with DNA aneuploidy. Aneuploidy could be a useful marker for therapies that target EGFR.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y, Oue N. Molecular Pathology of Gastric Cancer: Research and Practice. Pathol Res Pract. 2011; 207:608–12.CrossRefPubMed Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y, Oue N. Molecular Pathology of Gastric Cancer: Research and Practice. Pathol Res Pract. 2011; 207:608–12.CrossRefPubMed
2.
go back to reference Cervantes A, Roselló S, Roda D, Rodríguez-Braun E. The treatment of advanced gastric cancer: current strategies and future perspectives. Ann Oncol. 2008;19:103–07.CrossRef Cervantes A, Roselló S, Roda D, Rodríguez-Braun E. The treatment of advanced gastric cancer: current strategies and future perspectives. Ann Oncol. 2008;19:103–07.CrossRef
3.
go back to reference Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.CrossRef Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.CrossRef
4.
go back to reference Wang K, Yuen ST, Xu J, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46:573–82CrossRefPubMed Wang K, Yuen ST, Xu J, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46:573–82CrossRefPubMed
5.
go back to reference Mertens F, Johansson B, Mitelman F. Isochromosomes in neoplasia. Genes Chro- mosomes Cancer. 1994;10:221–30.CrossRefPubMed Mertens F, Johansson B, Mitelman F. Isochromosomes in neoplasia. Genes Chro- mosomes Cancer. 1994;10:221–30.CrossRefPubMed
7.
go back to reference Bang YJ. Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer. J Clin Gastroenterol. 2012;46:637–48CrossRefPubMed Bang YJ. Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer. J Clin Gastroenterol. 2012;46:637–48CrossRefPubMed
8.
go back to reference Ye D, Mendelsohn J, Fan Z. Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225. Oncogene. 1999; 18:731–38.CrossRefPubMed Ye D, Mendelsohn J, Fan Z. Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225. Oncogene. 1999; 18:731–38.CrossRefPubMed
9.
go back to reference Schlessinger J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science. 2004; 306:1506–07.CrossRefPubMed Schlessinger J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science. 2004; 306:1506–07.CrossRefPubMed
10.
go back to reference Kim JS, Kim MA, Kim TM, et al. Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favorable survival. Br J Cancer. 2009;100:732–38CrossRefPubMedPubMedCentral Kim JS, Kim MA, Kim TM, et al. Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favorable survival. Br J Cancer. 2009;100:732–38CrossRefPubMedPubMedCentral
11.
go back to reference Oki E, Baba H, Tokunaga E, et al. AKT phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Int. J. Cancer. 2005:117;376–80CrossRefPubMed Oki E, Baba H, Tokunaga E, et al. AKT phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Int. J. Cancer. 2005:117;376–80CrossRefPubMed
12.
go back to reference Radu OM, Foxwell T, Cieply K, Navina S, Dacic S, Nason KS, Davison JM. HER2 amplification in gastroesophageal adenocarcinoma: correlation of two antibodies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridization. Am J Clin Pathol. 2012; 137:583–94.CrossRefPubMedPubMedCentral Radu OM, Foxwell T, Cieply K, Navina S, Dacic S, Nason KS, Davison JM. HER2 amplification in gastroesophageal adenocarcinoma: correlation of two antibodies using gastric cancer scoring criteria, H score, and digital image analysis with fluorescence in situ hybridization. Am J Clin Pathol. 2012; 137:583–94.CrossRefPubMedPubMedCentral
13.
go back to reference Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004;351:337–45.CrossRefPubMed Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004;351:337–45.CrossRefPubMed
14.
go back to reference Ando K, Kakeji Y, Kitao H, et al. High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer. Cancer Sci. 2010;101:639–45.CrossRefPubMed Ando K, Kakeji Y, Kitao H, et al. High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer. Cancer Sci. 2010;101:639–45.CrossRefPubMed
15.
go back to reference Furuya T, Uchiyama T, Murakami T et al. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers. Clin Cancer Res. 2000;6:2815–20.PubMed Furuya T, Uchiyama T, Murakami T et al. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers. Clin Cancer Res. 2000;6:2815–20.PubMed
16.
go back to reference Seabright, M. (1971) A rapid banding technique for human chromosomes. Lancet. 1971;30:971–72.CrossRef Seabright, M. (1971) A rapid banding technique for human chromosomes. Lancet. 1971;30:971–72.CrossRef
17.
go back to reference Ciardiello F, Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res. 2001;7:2958–70.PubMed Ciardiello F, Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res. 2001;7:2958–70.PubMed
18.
go back to reference Galizia G, Lieto E, Ferraraccio F, et al. Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery. Ann Surg Oncol. 2006;13:823–35.CrossRefPubMed Galizia G, Lieto E, Ferraraccio F, et al. Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery. Ann Surg Oncol. 2006;13:823–35.CrossRefPubMed
19.
go back to reference Garcia I, Vizoso F, Martin A, Sanz L, Abdel-Lah O, Raigoso P, Garcia-Muniz JL. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Ann Surg Oncol. 2003;10:234–41.CrossRefPubMed Garcia I, Vizoso F, Martin A, Sanz L, Abdel-Lah O, Raigoso P, Garcia-Muniz JL. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Ann Surg Oncol. 2003;10:234–41.CrossRefPubMed
20.
go back to reference Galizia G, Lieto E, Orditura M, et al. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery. World J Surg. 2007;31:1458–68.CrossRefPubMed Galizia G, Lieto E, Orditura M, et al. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery. World J Surg. 2007;31:1458–68.CrossRefPubMed
21.
go back to reference Fusco N, Elena GR, Claudia DC. HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions. Mod Pathol. 2013; 26:1–9. Fusco N, Elena GR, Claudia DC. HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions. Mod Pathol. 2013; 26:1–9.
22.
go back to reference Masanori T, Kitada K. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res. 2012;18:5992–6000.CrossRef Masanori T, Kitada K. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res. 2012;18:5992–6000.CrossRef
23.
go back to reference Berg D, Wolff C, Malinowsky K, et al. Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR. J Cell Physiol. 2012;227:204–12.CrossRefPubMed Berg D, Wolff C, Malinowsky K, et al. Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR. J Cell Physiol. 2012;227:204–12.CrossRefPubMed
24.
go back to reference Almhanna K, Strosberg J, Malafa M. Targeting AKT protein kinase in gastric cancer. Anticancer Res. 2011;31:4387–92.PubMed Almhanna K, Strosberg J, Malafa M. Targeting AKT protein kinase in gastric cancer. Anticancer Res. 2011;31:4387–92.PubMed
25.
go back to reference Hudis C, Swanton C, Janjigian YY, et al. A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors. Breast Cancer Res. 2013;19:R110. doi:10.1186/bcr3577.CrossRef Hudis C, Swanton C, Janjigian YY, et al. A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors. Breast Cancer Res. 2013;19:R110. doi:10.​1186/​bcr3577.CrossRef
26.
go back to reference Baba H, Korenaga D, Kakeji Y, Haraguchi M, Okamura T, Maehara Y. DNA ploidy and its clinical implications in gastric cancer. Surgery 2002;131:S63–70.CrossRefPubMed Baba H, Korenaga D, Kakeji Y, Haraguchi M, Okamura T, Maehara Y. DNA ploidy and its clinical implications in gastric cancer. Surgery 2002;131:S63–70.CrossRefPubMed
27.
go back to reference Scaltriti M, Baselga J. The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res. 2006;12:5268–72.CrossRefPubMed Scaltriti M, Baselga J. The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res. 2006;12:5268–72.CrossRefPubMed
28.
go back to reference Zasadil LM, Britigan EM, Weaver BA. 2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells. Semin Cell Dev Biol. 2013;24:370–9.CrossRefPubMedPubMedCentral Zasadil LM, Britigan EM, Weaver BA. 2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells. Semin Cell Dev Biol. 2013;24:370–9.CrossRefPubMedPubMedCentral
29.
go back to reference Araujo SE, Bernardo WM, Habr-Gama A, Kiss DR, Cecconello I. DNA ploidy status and prognosis in colorectal cancer: a meta-analysis of published data. Dis Colon Rectum. 2007;50:1800–10.CrossRefPubMed Araujo SE, Bernardo WM, Habr-Gama A, Kiss DR, Cecconello I. DNA ploidy status and prognosis in colorectal cancer: a meta-analysis of published data. Dis Colon Rectum. 2007;50:1800–10.CrossRefPubMed
30.
go back to reference Habermann JK, Brucker CA, Freitag-Wolf S, et al. Genomic instability and oncogene amplifications in colorectal adenomas predict recurrence and synchronous carcinoma. Mod Pathol. 2011;24:542–55.CrossRefPubMed Habermann JK, Brucker CA, Freitag-Wolf S, et al. Genomic instability and oncogene amplifications in colorectal adenomas predict recurrence and synchronous carcinoma. Mod Pathol. 2011;24:542–55.CrossRefPubMed
31.
go back to reference Ly P, Eskiocak U, Kim SB, et al. Characterization of aneuploid populations with trisomy 7 and 20 derived from diploid human colonic epithelial cells. Neoplasia. 2011;13:348–357.CrossRefPubMedPubMedCentral Ly P, Eskiocak U, Kim SB, et al. Characterization of aneuploid populations with trisomy 7 and 20 derived from diploid human colonic epithelial cells. Neoplasia. 2011;13:348–357.CrossRefPubMedPubMedCentral
32.
go back to reference Ly P, Kim SB, Kaisani AA, Marian G, Wright WE, Shay JW. Aneuploid human colonic epithelial cells are sensitive to AICAR-induced growth inhibition through EGFR degradation. Oncogene. 2013;32:3139–46.CrossRefPubMedPubMedCentral Ly P, Kim SB, Kaisani AA, Marian G, Wright WE, Shay JW. Aneuploid human colonic epithelial cells are sensitive to AICAR-induced growth inhibition through EGFR degradation. Oncogene. 2013;32:3139–46.CrossRefPubMedPubMedCentral
33.
go back to reference Li L, Dutra A, Pak E, Labrie JE 3rd, et al. EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro Oncol. 2009;11:9–21.CrossRefPubMedPubMedCentral Li L, Dutra A, Pak E, Labrie JE 3rd, et al. EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro Oncol. 2009;11:9–21.CrossRefPubMedPubMedCentral
34.
go back to reference Mardin BR, Isokane M, Cosenza MR, Krämer A, Ellenberg J, Fry AM, Schiebel E. EGF-induced centrosome separation promotes mitotic progression and cell survival. Dev Cell. 2013;25:229–40.CrossRefPubMedPubMedCentral Mardin BR, Isokane M, Cosenza MR, Krämer A, Ellenberg J, Fry AM, Schiebel E. EGF-induced centrosome separation promotes mitotic progression and cell survival. Dev Cell. 2013;25:229–40.CrossRefPubMedPubMedCentral
Metadata
Title
Effect of EGFR and p-AKT Overexpression on Chromosomal Instability in Gastric Cancer
Authors
Yuichi Hisamatsu, MD, PhD
Eiji Oki, MD, PhD
Hajime Otsu, MD
Koji Ando, MD, PhD
Hiroshi Saeki, MD, PhD
Eriko Tokunaga, MD, PhD
Shinichi Aishima, MD, PhD
Masaru Morita, MD, PhD
Yoshinao Oda, MD, PhD
Yoshihiko Maehara, MD, PhD
Publication date
01-06-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 6/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5097-3

Other articles of this Issue 6/2016

Annals of Surgical Oncology 6/2016 Go to the issue